The NCERT Class 9 mathematics textbook 'Ganita Manjari' introduces a significant shift by emphasizing ancient Indian ...

The 196-page textbook – which prominently features ancient mathematics techniques and the work of several ancient Indian ...

Next, Classes II to V performed, their emcee were Ananya Arora and Gargi Chatterjee of Class XI. The school band spiced up the ambience. A play, Moksha, followed, depicting the court of Yamlok with ...

The Central Board of Secondary Education (CBSE) has rolled out its new curriculum, launching a phased implementation of the three-language formula from Class 6 and a two-level system of mathematics ...

NEW DELHI: The Central Board of Secondary Education (CBSE) has unveiled a comprehensive curriculum overhaul for the 2026–27 academic session, introducing a phased implementation of the three-language ...

The Central Board of Secondary Education (CBSE) has rolled out new curriculum, announcing a phased implementation of the three-language formula from Class 6 and two-level system of Mathematics and ...

Sanjay Sharma / TOI Education / Apr 04, 2026, 13:48 IST ...

Add Yahoo as a preferred source to see more of our stories on Google. This article is from Proof Positive, our friendly newsletter that explores the joys and peculiarities of math. Sign up today for a ...

The National Council of Educational Research and Training (NCERT) is thoroughly reviewing new Class 9 textbooks to avoid controversies following recent issues. Director Dinesh Prasad Saklani said some ...

JAC 9th Result 2026: The JAC 9th result has been announced by the Jharkhand Academic Council (JAC), Ranchi on its official website. The students who have participated in the Class 9 Jharkhand Board ...

“Subtraction!” most of the 3rd graders responded in chorus when asked what operation they needed to use to solve a problem. I noted that 100% of students were engaged and I gave the teacher an ...

CHARLESTON, S.C., April 13, 2026--(BUSINESS WIRE)--Leukogene Therapeutics, Inc., an early‑stage oncology company developing MHC class II-engager immunotherapies for immunologically cold cancers, today ...